Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 73 clinical trials
Characterization of Humoral and Cellular Immune Responses Elicited by Influenza Vaccination in Healthy Adults

Cellular and humoral immune responses before and after seasonal influenza vaccination will be assessed. Each year, up to 100 participants will be enrolled. To study age-specific differences in

Accepts healthy volunteers
vaccination
influenza vaccination
trivalent influenza vaccine
  • 4 views
  • 14 Nov, 2021
  • 1 location
Seasonal Influenza Vaccine Uptake Among Health Care Workers Following Awareness and Availability of Influenza Vaccine Supply in Tertiary Care Hospitals, Bangladesh

), increasing the likelihood of influenza transmission to colleagues and patients. Knowledge gap: Despite the World Health Organization recommendation for seasonal influenza vaccination among

  • 0 views
  • 20 Sep, 2022
  • 1 location
A Phase Ⅲ, Randomized, Double-blind and Controlled Clinical Trial to Evaluate the Immunogenicity and Safety of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Individuals Aged 3 Years and Older in Chile

The purpose of this study is to evaluate the safety and immunogenicity of Influenza vaccine (Split virion), Inactivated, Quadrivalent developed by Sinovac Biotech Co., Ltd. (Sinovac-QIV) as compared to a licensed comparator in Chile, Vaxigrip Tetra™ (Vaxigrip Tetra-QIV) in individuals aged 3 years and older.

Accepts healthy volunteers
  • 0 views
  • 19 Sep, 2022
  • 2 locations
An Open Phase I and Randomized, Double-blind, Controlled Phase III Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35months.

The study of quadrivalent influenza vaccine manufactured by Sinovac Biotech Co., Ltd will conduct in two phases,the phaseⅠclinical trial of the study will be open-label design,and the phase III clinical trial of the study will be randomized, double-blind, active controlled design.the purpose of this study is to evaluate the safety …

Accepts healthy volunteers
  • 0 views
  • 17 Sep, 2022
A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

The primary objective of this study is to evaluate the safety, reactogenicity, and humoral immunogenicity of mRNA-1020, mRNA-1030, and mRNA-1010 vaccines against vaccine-matched influenza A and B strains.

Accepts healthy volunteers
  • 14 views
  • 01 May, 2022
  • 15 locations
A Phase 3, Randomized, Stratified, Observer-blind, Active-Controlled Study to Evaluate the Immunogenicity and Safety of mRNA-1010 Seasonal Influenza Vaccine in Adults 18 Years and Older

The primary objectives of this study are to evaluate the humoral immunogenicity of mRNA-1010 relative to that of an active comparator against vaccine-matched influenza A and B strains at Day 29, and to evaluate the safety and reactogenicity of mRNA-1010.

Accepts healthy volunteers
  • 0 views
  • 16 Sep, 2022
  • 26 locations
Snack Foods and Their Impact on the Immune Response Following Influenza Vaccination (NutrImmune)

The purpose of this study is to evaluate the impact of replacing usual snacks with alternative snack foods on the immune response to influenza vaccination in a population of healthy, middle-aged

Accepts healthy volunteers
  • 0 views
  • 04 Oct, 2022
  • 1 location
Mindfulness-Based Stress Reduction for Family Caregivers of Dementia Patients

This study will examine the effects of the Mindfulness-Based Stress Reduction (MBSR) program and the Living Well program, compared to a control group, to see if the programs might be associated with better immune function (response to current influenza vaccine), physical and emotional health, and well-being.

Accepts healthy volunteers
dementia
  • 1 views
  • 15 Sep, 2022
  • 1 location
A Phase 1 Randomized, Observer-blind, Dose-escalation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of an mRNA-based Monovalent Influenza Vaccine Candidate in Healthy Younger and Older Adults

The purpose of this first-time-in-human (FTiH) study is to assess the safety, reactogenicity and immunogenicity of GlaxoSmithKline's (GSK) messenger RNA (mRNA)-based monovalent vaccine (GSK4382276A) candidate against influenza in healthy younger adults (YA) and older adults (OA).

Accepts healthy volunteers
  • 0 views
  • 18 Sep, 2022
  • 2 locations
Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine

This is a Phase 1b, randomized, double-blind, dose-escalating, age de-escalating, placebo-controlled study of a targeted 220 children, ages 6 months to 17 years, inclusive. This clinical trial is designed to assess the safety and immunogenicity of of one and two doses of Sing2016 M2SR H3N2 influenza vaccine (manufactured by FluGen) …

Accepts healthy volunteers
  • 0 views
  • 14 Apr, 2022
  • 4 locations